Orthopedic Devices - South Korea

  • South Korea
  • The projected revenue in the Orthopedic Devices market market in South Korea is estimated to reach €0.59bn in 2024.
  • It is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 6.54%, leading to a market volume of €0.81bn by 2029.
  • When compared globally, the United States is projected to generate the highest revenue of €14,850.00m in 2024.
  • South Korea's orthopedic devices market is witnessing a surge in demand for minimally invasive surgical procedures.

Key regions: France, Netherlands, Europe, Germany, Japan

 
Marché
 
Région
 
Comparaison de régions
 
Monnaie
 

Analyst Opinion

The Orthopedic Devices market in South Korea is experiencing significant growth and development.

Customer preferences:
Customers in South Korea are increasingly seeking orthopedic devices that are technologically advanced and offer high levels of precision and accuracy. They are willing to invest in innovative products that can provide better outcomes and improve their quality of life. Additionally, there is a growing preference for minimally invasive procedures and devices that can reduce recovery time and minimize scarring.

Trends in the market:
One of the key trends in the South Korean Orthopedic Devices market is the increasing adoption of robotic-assisted surgery. Robotic systems offer surgeons enhanced precision, control, and visualization during orthopedic procedures, leading to improved patient outcomes. The demand for robotic-assisted surgery is driven by the growing awareness among patients about the benefits of this technology and the willingness of healthcare providers to invest in advanced surgical systems. Another trend in the market is the rising popularity of 3D-printed orthopedic implants. 3D printing technology allows for the customization of implants based on the patient's specific anatomy, resulting in better fit and improved functionality. This technology also enables faster production and reduces the cost of manufacturing orthopedic implants. As a result, more healthcare providers in South Korea are incorporating 3D-printed implants into their practices.

Local special circumstances:
South Korea has a rapidly aging population, which is contributing to the growth of the Orthopedic Devices market. As people age, they are more prone to orthopedic conditions such as osteoarthritis and fractures, leading to an increased demand for orthopedic devices. Furthermore, the government in South Korea has implemented policies to support the development and adoption of advanced medical technologies, including orthopedic devices. This has created a favorable environment for market growth and innovation.

Underlying macroeconomic factors:
The South Korean economy has been growing steadily, which has resulted in increased disposable income and healthcare expenditure. This has allowed more individuals to afford orthopedic treatments and devices. Additionally, the government has implemented universal healthcare coverage, providing access to medical services for a larger portion of the population. The combination of economic growth and improved healthcare coverage has contributed to the expansion of the Orthopedic Devices market in South Korea. In conclusion, the Orthopedic Devices market in South Korea is experiencing growth and development due to customer preferences for technologically advanced and minimally invasive devices. The adoption of robotic-assisted surgery and 3D-printed implants is on the rise. The local special circumstances, such as the aging population and government support for medical technologies, further contribute to the market growth. The underlying macroeconomic factors, including economic growth and improved healthcare coverage, also play a significant role in the expansion of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Vue d’ensemble

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter

Contact

Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Camille Dubois
Camille Dubois
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)